OutSee
To add a bio or update company history, please click update information.
News from OutSee


OutSee
24 Jun 2025
OutSee raises £1.8m seed round led by Ahren Innovation Capital to advance AI-driven genomic target discovery
OutSee builds a predictive genomics platform that uses hypothesis-free AI modelling to discover new therapeutic targets, supporting precision medicine across neurological, rare and metabolic diseases.


OutSee
12 Jan 2026
OutSee completes its £2.5m seed round led by Ahren Innovation Capital for its genomic drug discovery platform
OutSee develops AI-driven genomics software that identifies disease targets directly from genetic data, supporting drug discovery by uncovering biological mechanisms missed by conventional analysis methods.
OutSee
- Life Sciences
- Cambridge, United Kingdom
- £4.3m
- outsee.co.uk
- Update Information
More venture news
- 15 Apr 2026

LightcastLightcast lands £20m in funding led by ARCH Venture Partners to advance single-cell analysis platform
EquityLife Sciences - 14 Apr 2026

HelicalHelical raises a £7.5m seed round led by redalpine to build virtual labs for pharma research
SeedLife Sciences - 31 Mar 2026

SemarionSemarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
EquityLife Sciences